- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT07946250
A Clinical Trial to Evaluate the Effects of Broc Shot Capsules on Skin Appearance and Comfort in Adults With Reactive, Blemish-Prone, or Hormonally Affected Skin
This is a randomized, double-blind, placebo-controlled, fully decentralized (remote) clinical trial evaluating the effects of Broc Shot Capsules on skin appearance and comfort in adults with reactive, blemish-prone, or hormonally affected skin. Fifty participants aged 18-65 years will be randomly assigned in a 1:1 ratio to receive either Broc Shot Capsules (active) or matched placebo capsules for 8 weeks.
Participants will take 2 capsules once daily and complete self-reported questionnaires and standardized self-captured skin photographs at Baseline, Week 4, and Week 8 via a secure online study platform. Expert dermatologist grading of photographs will be conducted remotely at each timepoint. The study is designed to substantiate consumer product claims related to visible skin improvement and participant-reported skin comfort, and is not intended to evaluate treatment of any clinical dermatological disease.
Tutkimuksen yleiskatsaus
Tila
Ehdot
Interventio / Hoito
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Gracia Walker
- Sähköposti: gracia@brocshot.com
Opiskelupaikat
-
-
Nevada
-
Las Vegas, Nevada, Yhdysvallat, 89101
- Citruslabs
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Adults aged 18 to 65 years (inclusive) at the time of consent.
- Self-reported skin concerns matching at least one of the following descriptions: I have red, itchy skin patches
- I have dry, flaky/scaley skin patches
- my skin has blemishes such as pimples, discoloured papules (small, tender bumps that are pink/red/purple/or darker than your natural skin tone) or pustules (a distinct white or yellow pus-filled center surrounded by a red base).
- Generally healthy adults who are willing and able to follow the study protocol for the full 8-week duration, including taking 2 capsules of the study product once daily for 8 consecutive weeks without skipping days, answering questionnaires at Baseline, Week 4, and Week 8, and following the photograph submission protocol at Baseline, Week 4, and Week 8.
- Willing to avoid initiating any new topical or oral skincare products, prescription medications targeting skin, or other dietary supplements specifically marketed for skin benefit during the study period.
- Participants currently using such products who have been using them consistently for at least 3 months prior to enrollment and are willing to continue unchanged throughout the study are eligible.
- Willing to maintain their current diet, lifestyle, sleep pattern, sun exposure habits, and skincare routine for the duration of the trial.
- Resides within the United States.
- Access to a smartphone or computer with internet connection and the ability to use the Citruslabs digital study platform.
Exclusion Criteria:
- Known allergy, hypersensitivity, or intolerance to broccoli, horseradish, other cruciferous vegetables (Brassicaceae family), or any component of the study product or placebo capsule.
- Currently pregnant, breastfeeding, or planning to become pregnant during the study period.
- Currently taking prescription anticoagulant medications (e.g., warfarin, apixaban, rivaroxaban) due to the potential for product ingredients to interact with anticoagulant activity.
- History of a severe or unstable medical condition that, in the opinion of the study team, would prevent safe participation or adherence to the protocol, including active cancer treatment.
- Currently using any oral, topical, or biologic prescription medication specifically indicated for a diagnosed dermatological condition, unless the regimen has been stable for at least 3 months and no changes are planned during the study period.
- Planned dermatological procedures during the study period (e.g., chemical peels, laser treatments, microneedling, injectable cosmetic procedures) that could confound skin appearance assessments.
- Currently enrolled in another clinical or consumer research study, or plans to enroll in any such study during the 8-week study period.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Kaksinkertainen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Placebo Comparator: Placebo Comparator
|
Participants will take 2 capsules once daily, with their first meal of the day, avoiding administration with hot or acidic liquids. |
|
Kokeellinen: BrocShot Collagen
|
Participants will take 2 capsules once daily, with their first meal of the day, avoiding administration with hot or acidic liquids. |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Clinician-Assessed Change in Overall Skin Appearance
Aikaikkuna: Baseline to Week 8
|
Change from Baseline in overall skin appearance graded by a qualified dermatologist reviewing participant-submitted digital photographs using a binary Yes/No improvement scale assessing overall skin health, pigmentation, dryness, brightness, scarring, blemishes, redness, and flaking |
Baseline to Week 8
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Participant-Reported Change in Skin Appearance
Aikaikkuna: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin appearance assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Clarity
Aikaikkuna: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin clarity assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Calmness
Aikaikkuna: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin calmness assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Visible Skin Concerns
Aikaikkuna: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported visible skin concerns assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Texture
Aikaikkuna: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin texture assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Luminosity
Aikaikkuna: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin luminosity assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Age Appearance
Aikaikkuna: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin age appearance assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Itching and Irritation
Aikaikkuna: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported itching and irritation assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Comfort
Aikaikkuna: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin comfort assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Confidence
Aikaikkuna: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin confidence assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
Yhteistyökumppanit ja tutkijat
Sponsori
Yhteistyökumppanit
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Arvioitu)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- BROCS-84181
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .